🇺🇸 FDA
Patent

US 10172951

Dendrimer based nanodevices for therapeutic and imaging purposes

granted A61KA61K31/198A61K31/405

Quick answer

US patent 10172951 (Dendrimer based nanodevices for therapeutic and imaging purposes) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jan 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/198, A61K31/405, A61K31/43, A61K31/57